Publicaciones en colaboración con investigadores/as de University of Amsterdam (33)

2023

  1. Author Correction: Discovery of 42 genome-wide significant loci associated with dyslexia (Nature Genetics, (2022), 54, 11, (1621-1629), 10.1038/s41588-022-01192-y)

    Nature Genetics

  2. Classifying asthma control using salivary and fecal bacterial microbiome in children with moderate-to-severe asthma

    Pediatric Allergy and Immunology, Vol. 34, Núm. 2

  3. Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium

    Kidney International Reports, Vol. 8, Núm. 10, pp. 2029-2042

  4. Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

    The Lancet Regional Health - Europe, Vol. 33

  5. Epigenome-Wide Association Studies of the Fractional Exhaled Nitric Oxide and Bronchodilator Drug Response in Moderate-to-Severe Pediatric Asthma

    Biomedicines, Vol. 11, Núm. 3

  6. Medication use in uncontrolled pediatric asthma: Results from the SysPharmPediA study

    European Journal of Pharmaceutical Sciences, Vol. 181

2022

  1. Discovery of 42 genome-wide significant loci associated with dyslexia

    Nature Genetics, Vol. 54, Núm. 11, pp. 1621-1629

  2. Improved Outcome of Infantile Oxalosis Over Time in Europe: Data From the OxalEurope Registry

    Kidney International Reports, Vol. 7, Núm. 7, pp. 1608-1618

  3. Multi-ancestry genome-wide association study of asthma exacerbations

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, Vol. 33, Núm. 6, pp. e13802

2021

  1. A system pharmacology multi-omics approach toward uncontrolled pediatric asthma

    Journal of Personalized Medicine, Vol. 11, Núm. 6

  2. Combined analysis of transcriptomic and genetic data for the identification of loci involved in glucocorticosteroid response in asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 4, pp. 1238-1243

  3. From Your Nose to Your Toes: A Review of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic‒Associated Pernio

    Journal of Investigative Dermatology, Vol. 141, Núm. 12, pp. 2791-2796

  4. Genome-wide association study of asthma exacerbations despite inhaled corticosteroid use

    European Respiratory Journal, Vol. 57, Núm. 5

  5. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  6. Identification of robo2 as a potential locus associated with inhaled corticosteroid response in childhood asthma

    Journal of Personalized Medicine, Vol. 11, Núm. 8

  7. LTA4H rs2660845 association with montelukast response in early and late-onset asthma

    PLoS ONE, Vol. 16, Núm. 9 September

2020

  1. Autoantibodies against type I IFNs in patients with life-threatening COVID-19

    Science, Vol. 370, Núm. 6515

  2. Chromatin regulators and their impact on DNA repair and G2 checkpoint recovery

    Cell Cycle, Vol. 19, Núm. 17, pp. 2083-2093

  3. Correction: Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritization (The Pharmacogenomics Journal, (2020), 20, 5, (621-628), 10.1038/s41397-019-0140-y)

    Pharmacogenomics Journal

  4. IL1RL1 gene variations are associated with asthma exacerbations in children and adolescents using inhaled corticosteroids

    Allergy: European Journal of Allergy and Clinical Immunology